Today: 20 March 2026
Subscribe
Browse Category

NYSE:RCUS 14 December 2025 - 8 January 2026

Arcus Biosciences (NYSE:RCUS) stock slides on Morgan Stanley downgrade as casdatifan 2026 timeline sharpens

Arcus Biosciences (NYSE:RCUS) stock slides on Morgan Stanley downgrade as casdatifan 2026 timeline sharpens

Arcus Biosciences shares dropped 9.3% to $21.05 Thursday after Morgan Stanley downgraded the stock and cut its price target to $20. The company highlighted a February data update and a Jan. 14 J.P. Morgan conference slot. BlackRock disclosed a 10.4% stake as of Dec. 31. President Juan C. Jaen reported selling 31,823 shares on Jan. 5 under a pre-set trading plan.
8 January 2026
··

Stock Market Today

  • Dow, Nasdaq Near Correction Amid Fourth Weekly Loss; Iran War Pressures Markets
    March 20, 2026, 11:20 AM EDT. The Dow Jones Industrial Average and Nasdaq are closing out a fourth consecutive losing week, edging closer to correction territory-defined as a 10% drop from recent highs. The Dow fell 128 points (0.3%) while the Nasdaq declined 0.8% on Friday amid ongoing uncertainty from the Iran war, which has unsettled global markets. The Dow is down 8.6% from its February peak; the Nasdaq has lost 8.7%. Key tech stocks including CrowdStrike, Shopify, and Meta led the Nasdaq's declines. Historically, only six of 27 corrections since 1974 have turned into bear markets (20% losses). Market analysts note geopolitical shocks, like the Iran war, typically prompt short-term dips followed by rapid recoveries. Rising oil prices driven by tensions in the Middle East add to inflation concerns and economic uncertainty.
Go toTop